(â‰¥3 months) glucocorticoids is strongly recommended over initiation of a csDMARD with longer-term glucocorticoids for DMARD-naive patients with moderate-to-high disease activity Although some patients may require longer-term glucocorticoids, this strong recommendation against longer-term glucocorticoid therapy is made because of its significant toxicity. Recommendations for DMARD-naive patients with low disease activity (Table 2) Hydroxychloroquine is conditionally recommended over other